Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05715463 · ClinicalTrials.gov registry record · NA
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
A NA study of Rheumatoid Arthritis and Psoriatic Arthritis, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 101
- Enrollment target
- 1
- Study location
NCT05715463: Active NA study of Rheumatoid Arthritis and Psoriatic Arthritis, sponsored by Brigham and Women's Hospital.
NCT05715463 is a NA study of Rheumatoid Arthritis and Psoriatic Arthritis that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 101 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05715463, a NA study of Rheumatoid Arthritis and Psoriatic Arthritis, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
Social determinants of health (SDoH), defined by the World Health Organization as "the conditions in which people are born, grow, work, live and age and the wider set of forces and systems shaping the conditions of daily life" are estimated to be responsible for nearly 90 percent of a person's health outcomes. SDoH are key contributors to racial, ethnic and socioeconomic disparities in care healthcare access and health outcomes. The goal of this clinical trial is to identify patients with inflammatory arthritis or with a systemic rheumatic condition with arthritis who may respond to the simplest and least expensive intervention to address their SDoH-related needs- a tailored list of resources, those who benefit from a community-based resource specialist to help address specific needs, and those who require a nurse-trained navigator to help both coordinate the services provided by the community-based specialist, and their medical and mental health care and needs. The main questions the clinical trial aims to answer are: 1. To test the efficacy of a rheumatology clinic-based nurse navigator and community resource specialist to reduce appointment no-shows and same-day cancellations in patients with systemic rheumatic conditions with arthritis. 2. To examine the cost-effectiveness of each of the different study interventions for individuals with systemic rheumatic conditions with arthritis with SDoH-related needs using questionnaires and cost-related care metrics. Participants will be randomly assigned to 1 of 3 arms. In Arm 1, patients will receive a cultivated list of resources related to the needs that patients indicate on the social determinants of health questionnaire. Arm 1 is the control arm which receives the current standard of care. In Arm 2, patients will receive the assistance of a community resource specialist (CRS) - an individual without formal medical training with community-based expertise. In Arm 3, patients will receive the assistance of a nurse pat
Primary Outcome
Patient no-shows will be measured through EPIC data from EDW, manual chart review and RPDR. The outcome will measure number of times that a patient has been designated 'no show' to an appointment with an ambulatory care provider.
Conditions Studied
Interventions
- OTHER Nurse Navigator
- OTHER Resource sheets
- OTHER Community Resource Specialist
Study Locations (1)
Massachusetts
- Brigham & Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What the registry record for NCT05715463 still lists
NCT05715463 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower).
The record links to 10 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 3 interventions - of which Nurse Navigator is the first listed.
NCT05715463 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05715463 about?
NCT05715463 is a clinical study titled "Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity". Social determinants of health (SDoH), defined by the World Health Organization as "the conditions in which people are born, grow, work, live and age and the wider set of forces and systems shaping the conditions of daily life" are estimated to be responsible for nearly 90 percent of a person's healt...
What is the current status of trial NCT05715463?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 101 participants. The study started on 2023-03-01. Estimated completion is 2026-12-01.
What conditions does trial NCT05715463 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Systemic Sclerosis, Ankylosing Spondylitis, Lupus.
What interventions are being tested in trial NCT05715463?
The interventions under investigation include: Nurse Navigator (OTHER), Resource sheets (OTHER), Community Resource Specialist (OTHER).
Who is sponsoring clinical trial NCT05715463?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05715463 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05715463's enrollment target sits among peer trials
101 116th of 197 higher than 82 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
RECRUITING · NA
-
Improving Hypertension Control in Rheumatoid Arthritis
RECRUITING · NA
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI